BIOMAT Database Logo BIOMAT Database Logo

[Immunobiologic characteristics of carbohydrate-containing preparations of Haemophilus influenzae]. 2010

O V Novikova, and N G Kalina, and N P Vaneeva, and S I Elkina, and M M Tokarskaia, and N E Iastrebova

OBJECTIVE Comparative assessment of immunobiological characteristics of 3 antigenic preparations containing capsular polysaccharide of Haemophilus influenzae type b (CPS Hib). METHODS The following preparations were assessed: CPS Hib obtained by using cetavlon; hydroxylamine preparation of Hib (HAP Hib); mixture of CPS Hib and lipooligosaccharide of non-typeable H. influenzae (LOS NTHi) detoxified by hydroxylamine hydrochloride. Effects of these preparations on immunophenotype of mononuclear leukocytes of mice spleen as well as on spectrum and level of cytokines in serum were studied. RESULTS It was shown that mixture of CPS Hib and detoxified LOS NTHi has low toxicity and most protective activity during Hib challenge leading to activation of innate immunity effectors and initiation of adaptive immune response. CONCLUSIONS Obtained data provide perspective for development of preparation able to protect from infections caused by both capsular and acapsular strains of H. influenzae.

UI MeSH Term Description Entries
D007113 Immunity, Innate The capacity of a normal organism to remain unaffected by microorganisms and their toxins. It results from the presence of naturally occurring ANTI-INFECTIVE AGENTS, constitutional factors such as BODY TEMPERATURE and immediate acting immune cells such as NATURAL KILLER CELLS. Immunity, Native,Immunity, Natural,Immunity, Non-Specific,Resistance, Natural,Innate Immune Response,Innate Immunity,Immune Response, Innate,Immune Responses, Innate,Immunity, Non Specific,Innate Immune Responses,Native Immunity,Natural Immunity,Natural Resistance,Non-Specific Immunity
D007962 Leukocytes White blood cells. These include granular leukocytes (BASOPHILS; EOSINOPHILS; and NEUTROPHILS) as well as non-granular leukocytes (LYMPHOCYTES and MONOCYTES). Blood Cells, White,Blood Corpuscles, White,White Blood Cells,White Blood Corpuscles,Blood Cell, White,Blood Corpuscle, White,Corpuscle, White Blood,Corpuscles, White Blood,Leukocyte,White Blood Cell,White Blood Corpuscle
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D002593 Cetrimonium Compounds Cetyltrimethylammonium compounds that have cationic detergent, antiseptic, and disinfectant activities. They are used in pharmaceuticals, foods, and cosmetics as preservatives; on skin, mucous membranes, etc., as antiseptics or cleansers, and also as emulsifiers. These compounds are toxic when used orally due to neuromuscular blockade. Cetyltrimethylammonium Compounds,Cetrimides,Compounds, Cetrimonium,Compounds, Cetyltrimethylammonium
D006192 Haemophilus Infections Infections with bacteria of the genus HAEMOPHILUS. Hemophilus Infections,Haemophilus influenzae Infection,Haemophilus influenzae Type b Infection,Hib Infection,Infections, Haemophilus,Infections, Hemophilus,Haemophilus Infection,Haemophilus influenzae Infections,Hemophilus Infection,Hib Infections,Infection, Haemophilus,Infection, Haemophilus influenzae,Infection, Hemophilus,Infection, Hib
D000077286 Cetrimonium Cetyltrimethylammonium compound whose salts and derivatives are used primarily as topical antiseptics. 1-Hexadecyltrimethylammonium Chloride,CTAB,CTAOH,Cetavlon,Cetrimide,Cetriminium,Cetrimonium Bromide,Cetrimonium Chloride,Cetrimonium Hydroxide,Cetrimonium Iodide,Cetrimonium Methosulfate,Cetrimonium Methyl Sulfate,Cetrimonium Monosulfate,Cetyltrimethylammonium Bromide,Cetyltrimethylammonium Chloride,HTAB Cpd,Hexadecyl Trimethyl Ammonium Bromide,Hexadecyl(trimethyl)azanium,Hexadecyltrimethylammonium Bromide,Hexadecyltrimethylammonium Octylsulfonate,Octylsulfonate, Hexadecyltrimethylammonium
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000942 Antigens, Bacterial Substances elaborated by bacteria that have antigenic activity. Bacterial Antigen,Bacterial Antigens,Antigen, Bacterial
D013154 Spleen An encapsulated lymphatic organ through which venous blood filters.
D014611 Vaccination Administration of vaccines to stimulate the host's immune response. This includes any preparation intended for active immunological prophylaxis. Immunization, Active,Active Immunization,Active Immunizations,Immunizations, Active,Vaccinations

Related Publications

O V Novikova, and N G Kalina, and N P Vaneeva, and S I Elkina, and M M Tokarskaia, and N E Iastrebova
Day care characteristics associated with Haemophilus influenzae disease. Haemophilus influenzae Study Group.
December 1990, American journal of public health,
O V Novikova, and N G Kalina, and N P Vaneeva, and S I Elkina, and M M Tokarskaia, and N E Iastrebova
Brain carbohydrate metabolism during experimental Haemophilus influenzae meningitis.
January 1979, Pediatric research,
O V Novikova, and N G Kalina, and N P Vaneeva, and S I Elkina, and M M Tokarskaia, and N E Iastrebova
Effect of irradiated haemophilus influenzae endotoxin preparations in mice.
January 1983, Acta microbiologica Hungarica,
O V Novikova, and N G Kalina, and N P Vaneeva, and S I Elkina, and M M Tokarskaia, and N E Iastrebova
Studies on haemophilus influenzae type characteristics.
January 1952, Acta pathologica et microbiologica Scandinavica,
O V Novikova, and N G Kalina, and N P Vaneeva, and S I Elkina, and M M Tokarskaia, and N E Iastrebova
Heat sensitivity of Haemophilus influenzae containing defective prophage.
December 1977, Journal of bacteriology,
O V Novikova, and N G Kalina, and N P Vaneeva, and S I Elkina, and M M Tokarskaia, and N E Iastrebova
Characterization of the immunoprotective antigen of ribosomal preparations from Haemophilus influenzae.
January 1978, Infection and immunity,
O V Novikova, and N G Kalina, and N P Vaneeva, and S I Elkina, and M M Tokarskaia, and N E Iastrebova
The inhibition of Haemophilus influenzae by certain agar and peptone preparations.
May 1974, Journal of medical microbiology,
O V Novikova, and N G Kalina, and N P Vaneeva, and S I Elkina, and M M Tokarskaia, and N E Iastrebova
Profiling of Haemophilus influenzae strain R2866 with carbohydrate-based covalent probes.
January 2021, Organic & biomolecular chemistry,
O V Novikova, and N G Kalina, and N P Vaneeva, and S I Elkina, and M M Tokarskaia, and N E Iastrebova
Plasmid containing a DNA ligase gene from Haemophilus influenzae.
May 1984, Journal of bacteriology,
O V Novikova, and N G Kalina, and N P Vaneeva, and S I Elkina, and M M Tokarskaia, and N E Iastrebova
Characteristics of major outer membrane proteins of Haemophilus influenzae.
August 1983, Journal of bacteriology,
Copied contents to your clipboard!